Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy
Status:
Unknown status
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
This prospective, randomized, controlled, multi-center clinical trial will evaluate the
effect and security of reh-acteoside therapy for patients of IgA nephropathy.